India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports

Zentiva as

20/08/2025 07:46

Aug 20 (Reuters) - Indian drugmaker Aurobindo Pharma ARBN.NS is leading the race to acquire Prague-based generic drugmaker Zentiva 1SKF401E.BV from private equity firm Advent International for up to $5.5 billion, the Economic Times reported on Wednesday, citing people aware of the matter.

However, Aurobindo Pharma, in a statement to exchanges, said no binding agreements have been signed by the company's board.

 (Reporting by Kashish Tandon in Bengaluru; Editing by Harikrishnan Nair)

 ((Kashish.Tandon@thomsonreuters.com; 8800437922;))